Market Report, "Argentina Pharmaceuticals & Healthcare Report Q1 2015", published

We expect increasing competitive pressure in the A rgentine pharmaceutical sector as South-South relations continue to develop. This is illustrated by the Argentine government recent authorization for Indian pharmaceutical firms to export finished formulations to Argentina. Argentina's debt default poses downside risk to economic activity in the next quarters, while we expect inflation and drug pricing controls to continue hampering the pharmaceutical market potential. The challenging business environment in the country will push more local pharmaceutical companies to continue seeking expansion, especially in other Latin American countries . In turn, undervalued local drugmakers could be acquisition targets for multinationals to enhance their footprint in the region, as illustrated by the recent acquisition of allergen immunotherapy firm Alergo Pharma by Stallergenes .

Full Report Details at
- http://www.fastmr.com/prod/912242_argentina_pharmaceuticals_healthcare_report_q1.aspx?afid=301

Headline Expenditure Projections

Pharmaceuticals: ARS39.30bn (USD7.18bn) in 2013 to ARS49.91bn (USD6.09bn) in 2014; +27.0% in local currency terms and -15.2% in US dollar terms. Forecast broadly in line with Q4 2014.

Healthcare: ARS220.18bn (USD40.20bn) in 2013 to ARS278.69bn (USD33.99bn) in 2014; +26.6% in local currency terms and -15.5% in US dollar terms. Forecast broadly in line with Q4 2014 in local currency terms and revised slightly downwards in US dollar terms.

Risk/Reward Indices : In Q1 2015, Argentina ranks as the sixth most attractive market in the Americas region under BMI's Pharmaceutical and Healthcare Risk/Reward Indices (RRIs). Posting a score of 54.5 out of 100, Argentina registered a substantial upward shift of three ranking positions from Q4 2014. However, the upbeat shift is mainly explained by deteriorating scores in regional peers and not by any significant improvement in the Argentine market score from the previous quarter. The Argentine pharmaceutical market will continue growing at a fast rate due in part to inflation.

Key Trends And...

The Argentina Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Argentina Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Argentinian pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's independent pharmaceutical and healthcare industry forecasts for Argentina to test other views - a key input for successful budgeting and strategic business planning in the Argentinian pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Turkey Pharmaceuticals & Healthcare Report Q1 2015
- Slovenia Pharmaceuticals & Healthcare Report Q1 2015
- Thailand Pharmaceuticals & Healthcare Report Q1 2015
- Kenya Pharmaceuticals & Healthcare Report Q1 2015
- Ukraine Pharmaceuticals & Healthcare Report Q1 2015